Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Sweetened Beverages and Pancreatic Cancer: Insights From Recent Epidemiological Data and Oncogenic Mechanisms.

Created on 29 Sep 2026

Authors

Ha Thi Thao Mai, Nilufar Mirzaeva, Do Tung Dac, Tran Tin Nghia, Mai Anh Thi Nguyen, J Luis Espinoza

Published in

Molecular nutrition & food research. Volume 70. Issue 19. Pages e70617.

Abstract

Hyperglycemia and altered carbohydrate metabolism may promote pancreatic cancer cell survival and proliferation. This narrative review critically evaluates epidemiological evidence on whether sugar-sweetened beverage (SSB) consumption is associated with pancreatic cancer risk and examines potential biological mechanisms involving glucose and fructose metabolism, oncogenic KRAS signaling, and metabolic reprogramming.
Earlier pooled analyses and a 2019 meta-analysis found no significant overall association between SSB consumption and pancreatic cancer risk. However, three subsequent studies, including a large prospective cohort from Taiwan and case-control studies from the United States and Jordan, reported positive associations in selected high-consumption groups. Differences in beverage definitions, dietary assessment methods, residual confounding, and study populations complicate comparisons. Mechanistic studies provide biological plausibility, suggesting that glucose and fructose metabolism and KRAS-driven metabolic reprogramming may enhance glycolysis, anabolic metabolism, nutrient acquisition, and cancer cell survival.
Evidence linking SSB consumption to pancreatic cancer remains inconsistent and insufficient to establish causality. Future research should standardize beverage definitions, distinguish SSBs from artificially sweetened beverages and fruit juices, use repeated dietary assessments, control metabolic and lifestyle confounders, include diverse populations, and integrate epidemiological data with metabolic and molecular biomarkers.

PMID:
42806724
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement